Literature DB >> 35306059

Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis.

Caroline Schwarz1, David Chromy2, Christine Bangert3, Michael Schwarz1, Mathias Jachs4, Thomas Reiberger4, Michael Gschwantler5.   

Abstract

Entities:  

Keywords:  HBV; HDV; allergy; bulevirtide; desensitization; hypersensitivity reaction

Mesh：

Substances：

Year:  2022        PMID： 35306059     DOI： 10.1016/j.jhep.2022.03.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   30.083


× No keyword cloud information.
  2 in total

Review 1.  Recent breakthroughs in the treatment of chronic hepatitis Delta.

Authors:  Giuseppina Brancaccio; Laura Gaeta; Alessandro Vitale; Giovanni B Gaeta
Journal:  Infez Med       Date:  2022-06-01

2.  Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-results of a "real world" study.

Authors:  Mathias Jachs; Caroline Schwarz; Marlene Panzer; Teresa Binter; Stephan W Aberle; Lukas Hartl; Kristina Dax; Elmar Aigner; Albert F Stättermayer; Petra Munda; Ivo Graziadei; Heidemarie Holzmann; Michael Trauner; Heinz Zoller; Michael Gschwantler; Mattias Mandorfer; Thomas Reiberger; Peter Ferenci
Journal:  Aliment Pharmacol Ther       Date:  2022-05-05       Impact factor: 9.524
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.